99 related articles for article (PubMed ID: 1979272)
1. Time course of the effect of intravenous dimetindene maleate.
Rehn D; Geissler H; Schönbrunn U; Lukas H; Hennings G
Eur J Clin Pharmacol; 1990; 39(2):137-41. PubMed ID: 1979272
[TBL] [Abstract][Full Text] [Related]
2. Effect-time-relation of the H1-receptor antagonist dimethindene maleate following intravenous injection.
Rehn D; Geissler H; Schönbrunn U; Lukas H; Hennings G
Agents Actions; 1990 Apr; 30(1-2):178-81. PubMed ID: 1973583
[TBL] [Abstract][Full Text] [Related]
3. Effect-kinetic characterization of dimethindene maleate following oral administration (Fenistil, Tropfen).
Rehn D; Geissler H; Schuster O; Lukas H; Hennings G
Fundam Clin Pharmacol; 1990; 4(6):673-83. PubMed ID: 2096106
[TBL] [Abstract][Full Text] [Related]
4. Effect time-course of the inhibition of histamine induced skin reactions by orally applied dimethindene maleate.
Rehn D; Geissler H; Schuster O; Lukas H; Hennings G
Agents Actions; 1991 May; 33(1-2):221-4. PubMed ID: 1680275
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic dose finding of dimetindene in a sustained release formulation.
Horak F; Jäger S; Nirnberger G; Berger U; Andresen L; Vix JM; Rehn D
Arzneimittelforschung; 1993 Nov; 43(11):1193-5. PubMed ID: 8292063
[TBL] [Abstract][Full Text] [Related]
6. The influence of dimetindene maleate on the endogenous hydrocortisone synthesis suppressing potency of betamethasone.
Rehn D; Haack D; Vecsei P; Hennings G
Arzneimittelforschung; 1985; 35(6):970-2. PubMed ID: 2862878
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of dimetindene after intravenous and oral administration to healthy volunteers.
Arnera V; Wermeille M; Wellman M; Llull JB; Althaus MA; Balant LP
Arzneimittelforschung; 1990 Dec; 40(12):1346-8. PubMed ID: 2095130
[TBL] [Abstract][Full Text] [Related]
8. The effect of topical dimethindene maleate on weal reactions.
Humphreys F; Shuster S
Br J Clin Pharmacol; 1987 Feb; 23(2):234-6. PubMed ID: 2881575
[TBL] [Abstract][Full Text] [Related]
9. Administration of H1 and H2 antagonists for chemoprophylaxis: a double-blind, placebo-controlled study in healthy volunteers.
Doenicke A; Moss J; Toledano A; Hoernecke R; Lorenz W; Ostwald P
J Clin Pharmacol; 1997 Feb; 37(2):140-6. PubMed ID: 9055140
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical dimetindene in experimentally induced pruritus and weal and flare reactions.
Lever LR; Hill S; Dykes PJ; Marks R
Skin Pharmacol; 1991; 4(2):109-12. PubMed ID: 1878244
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K
Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716
[TBL] [Abstract][Full Text] [Related]
12. Premedication with H1 and H2 blocking agents reduces the incidence of postoperative nausea and vomiting.
Doenicke AW; Hoernecke R; Celik I
Inflamm Res; 2004 Aug; 53 Suppl 2():S154-8. PubMed ID: 15338068
[TBL] [Abstract][Full Text] [Related]
13. The influence of dimetindene maleate (Fenistil) on the pharmacokinetic profile of betamethasone.
Rehn D; Gundert-Remy U; Weber E; Hennings G
Biopharm Drug Dispos; 1984; 5(3):291-5. PubMed ID: 6148971
[No Abstract] [Full Text] [Related]
14. The time course of action of three differing doses of noberastine, a novel H1-receptor antagonist, on histamine-induced skin wheals and the relationship to plasma drug concentrations in normal human volunteers.
Wood-Baker R; Emanuel MB; Hutchinson K; Howarth PH
Br J Clin Pharmacol; 1993 Feb; 35(2):166-70. PubMed ID: 8095149
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective biotransformation of the chiral antihistaminic drug dimethindene in humans and rats.
Prien D; Rehn D; Blaschke G
Arzneimittelforschung; 1997 May; 47(5):653-8. PubMed ID: 9205781
[TBL] [Abstract][Full Text] [Related]
16. Effects of dimethindene maleate on psychomotor performance in the oculodynamic test compared with placebo and loratadine.
Englisch W; Rehn D; Schaffler K; Wauschkuhn CH
Arzneimittelforschung; 1996 Sep; 46(9):887-90. PubMed ID: 8876938
[TBL] [Abstract][Full Text] [Related]
17. Dose-related control of allergic rhinitis symptoms by a H1-receptor antagonist. Finding the proper doses [correction of dosis] of dimethindene maleate in patients with allergic rhinitis.
Horak FF; Jäger S; Nirnberger G; Berger U; Andresen I; Vix JM; Rehn D
Int Arch Allergy Immunol; 1994; 103(3):298-302. PubMed ID: 7906578
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
Kyrein HJ; Horak F; Nirnberger G; Rehn D
Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the local antihistaminic activity of dimetindene maleate by a quantitative method.
Rampini E; Oberhauser V; Nunzi E
Dermatologica; 1978; 157(2):105-9. PubMed ID: 27397
[TBL] [Abstract][Full Text] [Related]
20. Antihistaminic efficacy of Ranitidine with & without Dimethendine maleate on histamine-induced cutaneous reactions.
Chauhan CK; Shahani SR
Indian J Med Res; 1992 Apr; 96():128-32. PubMed ID: 1358821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
